GAPR-1 belongs to the CAP superfamily of proteins and is attached to the Golgi membrane through two features: an N-myristoyl group, a 14-carbon fatty acid chain chemically linked to the protein’s N-terminus, and a patch of ionic interactions with negatively charged lipids. To dissect how these features govern membrane binding, the team turned to molecular dynamics simulations, an approach that models every atom of a protein and a lipid bilayer over time and allows researchers to observe how the two interact at a level of detail inaccessible to most experimental techniques. The simulations revealed something subtle but consequential. When GAPR-1 docked onto a negatively charged lipid bilayer, it did not settle randomly. Instead, it adopted a preferred orientation, one stabilized by two specific lysine residues, at positions 7 and 33 of the amino acid sequence, which reach down and engage the acidic headgroups of the membrane.

That observation raised an obvious experimental question: if the orientation matters, what happens when it is disrupted? The researchers answered this by substituting the two lysines with glutamine, a mutation that preserves the overall size of the residues but removes their positive charge. In silico, the substitution changed the preferred membrane orientation of GAPR-1, confirming that the electrostatic contacts made by Lys7 and Lys33 are not incidental but are the structural determinants of how the protein positions itself at the membrane surface. The simulations also uncovered a second layer of control. When the myristoyl group was deleted from the model, GAPR-1 remained docked to the lipid bilayer, held there by its ionic interactions, but it lost its preferred orientation and began to wander across the membrane surface. The fatty acid anchor, in other words, does more than tether the protein to the membrane; it constrains the dynamics of the protein at that surface, limiting its motional freedom and locking in a defined posture.

To test whether this computational picture held up in living cells, the team moved to Saccharomyces cerevisiae, baker’s yeast, a workhorse organism for studying protein myristoylation and membrane association. They expressed a mutant version of GAPR-1 in which Lys7 was replaced by glutamine, designated [K7Q]GAPR-1. The result was twofold and unexpected. First, the mutation prevented the protein from being myristoylated at all, indicating that the positive charge at position 7 is somehow required for the enzymatic attachment of the fatty acid chain to the N-terminus. Second, even the fraction of protein that reached the membrane was severely impaired in its ability to form condensates, the dense clusters of oligomerized protein that wild-type GAPR-1 assembles on membrane surfaces.

Condensate formation was also blocked by a more direct intervention: mutating glycine at position 2, the residue that carries the myristoyl group, to alanine, a change that abolishes myristoylation by design. This established a clear causal chain running from the fatty acid anchor, through membrane orientation, to the assembly of higher-order protein structures on the Golgi surface. But the two mutants were not equivalent in every respect, and the difference between them proved to be the most biologically revealing finding of the study. While [G2A]GAPR-1, which lacks the myristoyl group but retains Lys7, could still interact with beclin 1 when co-expressed in yeast cells, [K7Q]GAPR-1 could not. The lysine-to-glutamine substitution had destroyed the protein’s capacity for hetero-oligomerization with its autophagy partner, independent of its myristoylation status.

The functional consequences of that lost interaction were confirmed in human cells. Beclin 1 is a core component of the autophagy initiation machinery, and GAPR-1 is known to interfere with beclin 1-dependent autophagy when overexpressed. When the researchers expressed the [K7Q] mutant in human cells, it failed to modulate autophagy in the way that the wild-type protein does, demonstrating that the membrane orientation defect translates directly into a loss of cellular function rather than being merely a biophysical curiosity. Taken together, the data show that GAPR-1 requires a defined orientation at the membrane to control both its homo-oligomerization into condensates and its hetero-oligomerization with beclin 1, and that this orientation is produced by the joint action of a charged residue and a lipid anchor.

Perhaps the most far-reaching implication of the study concerns myristoylation itself. N-myristoylation is one of the most common lipid modifications in eukaryotic cells, decorating hundreds of proteins involved in signaling, membrane trafficking, and cancer biology. The classical view assigns the myristoyl group a straightforward role as a hydrophobic anchor that increases membrane affinity. This study proposes something qualitatively different: by constraining the rotational and translational dynamics of a docked protein, myristoylation determines which protein orientations are accessible and which are favored. The authors suggest that this regulatory function, in which the fatty acid acts as a kind of orientational gimbal rather than a simple tether, may be relevant across the entire myristoylated proteome, adding a new dimension to how lipid modifications shape protein behavior at membranes.

The work also connects to a broader and rapidly growing area of cell biology: biomolecular condensates. These membraneless assemblies, formed by phase separation of proteins and nucleic acids, have been implicated in everything from gene regulation to neurodegenerative disease, and the machine-learning-suggested subject classification of the article places it squarely in the territory of biomolecular phase separation. By showing that a specific membrane orientation is a prerequisite for GAPR-1 condensate formation, the study adds membranes themselves, and the precise geometry of protein-membrane contacts, to the list of factors that determine where and how condensates assemble in cells.

Technically, the study is a showcase of how modern computational and experimental methods can be interlocked. The molecular dynamics simulations, run on the ARCHER2 and Sulis supercomputing facilities through the UK’s HECBioSim consortium, identified the orientation-defining residues and the dynamic role of the myristoyl group; mass spectrometry confirmed the myristoylation defects in the mutants; and fluorescence microscopy in yeast and human cells linked the structural findings to condensate formation, beclin 1 binding, and autophagy regulation. The paper, which was published as an open-access article and shared early under Springer Nature’s accelerated publication model, was supported by the China Scholarship Council, Wellcome, and UK research councils.

For researchers studying autophagy, the results offer a concrete mechanistic handle on how GAPR-1 influences beclin 1, a protein whose dysregulation is implicated in cancer and neurodegeneration. For the wider membrane biology community, the study reframes a familiar lipid modification as a director of molecular choreography, ensuring that proteins arriving at a membrane surface do not merely stick, but arrive facing the right way to do their jobs.

Unlike stably folded protein domains, intrinsically disordered regions lack a fixed 3D conformation. Despite this flexibility, IDRs fulfil critical roles in cellular processes such as signal transduction, molecular recognition, and the formation of biomolecular condensates—dense, membrane-less organelles that orchestrate biochemical reactions. Roughly one-third of all protein regions fall into this category, highlighting their prevalence and significance in cellular biochemistry. However, the absence of a definitive spatial structure combined with low sequence conservation across species has historically hindered detailed functional predictions based solely on motif recognition.

The research team focused their investigation on a particularly essential IDR in the yeast protein Abf1, a model system that allows for versatile experimental manipulation. By engineering and testing over 150 distinct variants of Abf1’s disordered domain, the team systematically dissected which alterations disrupted or preserved its native function. Their high-throughput mutagenesis approach was designed to test not only naturally occurring motifs but also newly synthesized sequences, enabling a broad exploration of the functional landscape accessible to these flexible regions.

The results revealed that functionality within IDRs does not derive solely from the presence of specific linear sequence motifs—short, defined stretches of amino acids that mediate precise molecular interactions. Equally crucial is the underlying chemical context of the disordered region, including properties such as net negative charge and the hydrophilicity or hydrophobicity of constituent amino acids. This chemical milieu modulates the physical behavior of the IDR, influencing how it interacts with binding partners and participates in cellular assemblies. It is the nuanced balance between discrete motif presence and the holistic biochemical environment that ultimately dictates protein functionality.

One of the study’s most striking discoveries was the functional redundancy afforded by the chemical context within IDRs. The researchers demonstrated that an otherwise indispensable short linear binding motif could be rendered nonessential if the surrounding amino acid composition was adjusted accordingly. For instance, enhancing negative charge density or altering solubility characteristics could compensate for the loss of a critical motif, preserving the protein’s overall activity. This finding challenges the traditional dogma that discrete motifs must be absolutely conserved and underscores the adaptive flexibility of IDRs.

Conversely, the study found that simply preserving the overall amino acid composition without maintaining key motifs or a complementary chemical context was insufficient to retain function. The interplay is therefore bidirectional and complex: linear sequence motifs require a supportive chemical environment, and the broader chemical characteristics depend on the positioning and presence of specific motifs to realize biological activity. This multifaceted relationship constructs a “functional landscape,” where multiple molecular solutions can achieve the same cellular outcome.

Professor Philipp Korber, leading the LMU research group, emphasizes the paradoxical nature of IDRs: “They are biologically indispensable yet defy straightforward classification by classical sequence alignment or structural analysis.” His collaboration with Alex Holehouse, a prominent figure in biochemistry and molecular biophysics at Washington University, helped elucidate the physicochemical principles underlying this paradox. Their joint efforts underscore the necessity of integrating chemical physicochemical parameters alongside primary sequence motifs when investigating protein function.

This conceptual breakthrough expands the theoretical evolutionary space in which intrinsically disordered regions operate. Prior to this work, evolutionary interpretations focused predominantly on motif conservation; however, this study reveals that IDRs can tolerate a wide spectrum of sequence variability by leveraging compensatory chemical properties. Such plasticity likely facilitates rapid adaptation and diversification of protein functions throughout evolution without detrimental loss of biological roles, an insight with profound implications for evolutionary biology.

From a biomedical perspective, these findings offer novel avenues for understanding disease-associated mutations within IDRs. Many pathogenic mutations affect these flexible segments, complicating efforts to predict their functional consequences using traditional bioinformatics tools. Recognizing that IDR function arises from a combination of motifs and chemical environment equips researchers with a more holistic framework to interpret variant effects. This advance could enhance predictive models for protein dysfunction in diseases ranging from neurodegenerative disorders to cancer.

Furthermore, the study paves the way for rational design of synthetic proteins with customized disordered regions. By tuning motifs and their chemical context, protein engineers can create flexible domains tailored for specific interactions or assembly properties. Such synthetic IDRs may find applications in biotechnology, therapeutic protein design, and synthetic biology, where conventional folded protein domains may lack the necessary versatility and dynamism.

In essence, this research reframes our understanding of intrinsically disordered regions as dynamic, adaptable landscapes shaped by an intricate balance of discrete sequence motifs and the physicochemical nature of surrounding residues. The functional plurality and robustness endowed by this balance elucidate how cells exploit protein disorder to regulate complex processes, maintain resilience, and evolve innovative biological functions. As the field of protein science continues to evolve, the integration of sequence and chemical specificity promises to yield richer insights into the molecular fabric of life.

The study’s comprehensive approach also advances methodologies in protein biophysics, combining mutagenesis, biochemical assays, and computational analyses that interrelate molecular structure, chemistry, and functional output. Such interdisciplinary collaboration exemplifies the transformative potential of merging theoretical and experimental paradigms in modern molecular biology, heralding a new era of precision understanding of the cellular proteome’s most elusive components.

Subject of Research: Intrinsically disordered protein regions (IDRs) and their functional mechanisms
Article Title: Sequence and chemical specificity define the functional landscape of intrinsically disordered regions
News Publication Date: 12-Feb-2026
Web References: DOI: 10.1038/s41556-025-01867-8
Keywords: Intrinsically disordered regions, protein flexibility, linear motifs, chemical context, protein evolution, molecular interactions, biomolecular condensates, yeast Abf1 protein, protein engineering, disease mutations